LUCD Lucid Diagnostics: Quarterly Revenue Growth

Symbol and logo of brand Lucid Diagnostics, Inc. (LUCD)

The success of Lucid Diagnostics Inc. (LUCD) relies on the recognition of its methodologies by associations and insurance coverage for esophageal cancer tests. Quarterly sales growth dynamics demonstrate business adaptation, where the latest parameter stands at -0.70. The integration of diagnostics into gastroenterologist protocols ensures a steady stream of orders and margins. However, high promotion costs are creating a cash gap that is depleting the company's cash reserves.

LUCD (Lucid Diagnostics, Inc) Sales Growth QoQ history from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Lucid Diagnostics (LUCD)

- stock price and consensus target price:
Fundamental company analysis:Lucid Diagnostics, Inc (LUCD)
Manufactured products of luciddx.com

The lack of alternatives for the Lucid Diagnostics Inc. (LUCD) molecular esophageal cancer test provides the company with exceptional pricing power. This market dominance is directly reflected in sales dynamics, measured by the estimated revenue change for the current quarter relative to the same period last year. This metric assesses the pace of business scaling, allowing for the identification of asset overheating during sharp growth acceleration. Analyzing the quarterly revenue growth rate helps investors recognize the risk of a price correction in a timely manner should the trend shift.

Competitors of Lucid Diagnostics Inc. (LUCD)

A - Revenue Growth QoQ|Quarterly Sales Growth Rate Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Quarterly Sales Growth|Quarterly Sales Growth Cologuard|RVTY (Revvity Corp) - Quarterly Revenue Growth|Quarterly Revenue Growth Bio-Rad Laboratories Inc|Quarterly Sales Growth NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Quarterly Revenue Increase|Revenue Growth QoQ QuidelOrtho Inc. QDEL|Quarterly Revenue Growth OPKO Health Inc OPK|CareDx Inc - Quarterly Revenue Growth|Quarterly Revenue Increase MRVI (Maravai)|FLGT: Quarterly Revenue Growth|LAB (Standard BioTools Inc.) - Revenue Growth QoQ|Revenue Growth QoQ Cytek Biosciences Inc|Quarterly Revenue Growth Rate OraSure OSUR|Quarterly Sales Growth XGN (Exagen Diagnostics)|Quarterly Sales Growth Rate MDxHealth Inc.|Revenue Growth QoQ Prenetics PRE|Insight Molecular (IMDX) - Quarterly Revenue Growth Rate|Trinity Biotech Corp - Quarterly Revenue Growth|Quarterly Sales Growth Rate ProPhase PRPH|AIMD: Quarterly Revenue Growth|CODX - Quarterly Sales Growth Rate|Revenue Growth QoQ Heart Test Laboratories, Inc.|Revenue Growth QoQ BMRA|Quarterly Revenue Growth CDIO|Onconetix - Sales Growth QoQ|Revenue Growth QoQ viraxbiolabs.com VRAX|Quarterly Sales Growth Rate Bluejay (BJDX)|AWH: Quarterly Sales Growth|Quarterly Sales Growth Rate Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Revenue Growth QoQ|Revenue Dynamics QoQ ENZ (Enzo)|Sales Growth QoQ Fresh2 (FRES)|Genetic Technologies (GENE) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ME|Revenue Growth QoQ PMD (Psychemedics Corporation)